Pharming Group N.V. ADS, each representing 10 ordinary shares (PHAR) is a publicly traded Healthcare sector company. As of August 25, 2026, PHAR trades at $11.87 with a market cap of $838.72M and a P/E ratio of 0.00. PHAR moved +0.00% today. Year to date, PHAR is -35.14%; over the trailing twelve months it is -16.35%. Its 52-week range spans $7.50 to $21.34. Analyst consensus is buy with an average price target of $37.50. Rallies surfaces PHAR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
PHAR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PHAR recently traded at $11.87. Market cap is $838.72M. P/E ratio is 0.00. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $11.87 |
| Market Cap | $838.72M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $21.34 |
| 52-Week Low | $7.50 |
| Volume | 10.06K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
2 analysts cover PHAR: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $37.50.